{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:32:08Z","timestamp":1792672328089,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"7619","license":[{"start":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T00:00:00Z","timestamp":1470614400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1038\/nature19339","type":"journal-article","created":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T09:41:15Z","timestamp":1470649275000},"page":"229-233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":410,"title":["Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness"],"prefix":"10.1038","volume":"537","author":[{"given":"Shilpi","family":"Khare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Advait S.","family":"Nagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Biggart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin H.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren C.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Whitney","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey J. N.","family":"Mathison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmarie","family":"Myburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-Yun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Robert","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn L.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Stinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ianne C.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Ballard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vince","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Groessl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Federe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel X. Y.","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Venable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badry","family":"Bursulaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranab K.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen","family":"Spraggon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansgar","family":"Brock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy C.","family":"Mottram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick S.","family":"Buckner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasa P. S.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben G.","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tove","family":"Tuntland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Molteni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Glynne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frantisek","family":"Supek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,8]]},"reference":[{"key":"BFnature19339_CR1","unstructured":"Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis. World Health Organization, WHO Technical Report Series 975, 1\u2013100 (2012)"},{"key":"BFnature19339_CR2","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1126\/science.1112181","volume":"309","author":"NM El-Sayed","year":"2005","unstructured":"El-Sayed, N. M. et al. Comparative genomics of trypanosomatid parasitic protozoa. Science 309, 404\u2013409 (2005)","journal-title":"Science"},{"key":"BFnature19339_CR3","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1126\/science.aaa3683","volume":"348","author":"G Bilbe","year":"2015","unstructured":"Bilbe, G. Infectious diseases. Overcoming neglect of kinetoplastid diseases. Science 348, 974\u2013976 (2015)","journal-title":"Science"},{"key":"BFnature19339_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1517\/14656566.2015.973850","volume":"16","author":"S Sundar","year":"2015","unstructured":"Sundar, S. & Chakravarty, J. An update on pharmacotherapy for leishmaniasis. Expert Opin. Pharmacother. 16, 237\u2013252 (2015)","journal-title":"Expert Opin. Pharmacother."},{"key":"BFnature19339_CR5","doi-asserted-by":"crossref","unstructured":"Nagle, A. S. et al. Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis. Chem. Rev. (2014)","DOI":"10.1021\/cr500365f"},{"key":"BFnature19339_CR6","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1056\/NEJMra1410150","volume":"373","author":"C Bern","year":"2015","unstructured":"Bern, C. Chagas\u2019 Disease. N. Engl. J. Med. 373, 456\u2013466 (2015)","journal-title":"N. Engl. J. Med."},{"key":"BFnature19339_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1087057114550585","volume":"20","author":"E Chatelain","year":"2015","unstructured":"Chatelain, E. Chagas disease drug discovery: toward a new era. J. Biomol. Screen. 20, 22\u201335 (2015)","journal-title":"J. Biomol. Screen."},{"key":"BFnature19339_CR8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S1474-4422(12)70296-X","volume":"12","author":"PG Kennedy","year":"2013","unstructured":"Kennedy, P. G. Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness). Lancet Neurol. 12, 186\u2013194 (2013)","journal-title":"Lancet Neurol."},{"key":"BFnature19339_CR9","unstructured":"Control of the leishmaniases. World Health Organization, WHO Technical Report Series 949, 37\u201339 (2010)"},{"key":"BFnature19339_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0924-8579(99)00133-8","volume":"13","author":"V Yardley","year":"2000","unstructured":"Yardley, V. & Croft, S. L. A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis. Int. J. Antimicrob. Agents 13, 243\u2013248 (2000)","journal-title":"Int. J. Antimicrob. Agents"},{"key":"BFnature19339_CR11","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1128\/AAC.00014-08","volume":"52","author":"TP Dorlo","year":"2008","unstructured":"Dorlo, T. P. et al. Pharmacokinetics of miltefosine in Old World cutaneous leishmaniasis patients. Antimicrob. Agents Chemother. 52, 2855\u20132860 (2008)","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnature19339_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/qjmed\/hct116","volume":"107","author":"BS McGwire","year":"2014","unstructured":"McGwire, B. S. & Satoskar, A. R. Leishmaniasis: clinical syndromes and treatment. QJM 107, 7\u201314, (2014)","journal-title":"QJM"},{"key":"BFnature19339_CR13","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.348.6232.296-b","volume":"348","author":"PJ Hotez","year":"2015","unstructured":"Hotez, P. J. Combating the next lethal epidemic. Science 348, 296\u2013297 (2015)","journal-title":"Science"},{"key":"BFnature19339_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.0105-2896.2004.00185.x","volume":"201","author":"D Sacks","year":"2004","unstructured":"Sacks, D. & Anderson, C. Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice. Immunol. Rev. 201, 225\u2013238 (2004)","journal-title":"Immunol. Rev."},{"key":"BFnature19339_CR15","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1128\/AAC.50.4.1238-1244.2006","volume":"50","author":"KG Nelson","year":"2006","unstructured":"Nelson, K. G., Bishop, J. V., Ryan, R. O. & Titus, R. Nanodisk-associated amphotericin B clears Leishmania major cutaneous infection in susceptible BALB\/c mice. Antimicrob. Agents Chemother. 50, 1238\u20131244 (2006)","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnature19339_CR16","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jacc.2013.05.046","volume":"62","author":"MC Nunes","year":"2013","unstructured":"Nunes, M. C. et al. Chagas disease: an overview of clinical and epidemiological aspects. J. Am. Coll. Cardiol. 62, 767\u2013776 (2013)","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnature19339_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.actatropica.2010.03.008","volume":"115","author":"JR Coura","year":"2010","unstructured":"Coura, J. R. & Borges-Pereira, J. Chagas disease: 100 years after its discovery. A systemic review. Acta Trop. 115, 5\u201313 (2010)","journal-title":"Acta Trop."},{"key":"BFnature19339_CR18","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1056\/NEJMct1014204","volume":"364","author":"C Bern","year":"2011","unstructured":"Bern, C. Antitrypanosomal therapy for chronic Chagas\u2019 disease. N. Engl. J. Med. 364, 2527\u20132534 (2011)","journal-title":"N. Engl. J. Med."},{"key":"BFnature19339_CR19","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1128\/AAC.01662-13","volume":"58","author":"R Viotti","year":"2014","unstructured":"Viotti, R. et al. Towards a paradigm shift in the treatment of chronic Chagas disease. Antimicrob. Agents Chemother. 58, 635\u2013639 (2014)","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnature19339_CR20","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","volume":"370","author":"I Molina","year":"2014","unstructured":"Molina, I. et al. Randomized trial of posaconazole and benznidazole for chronic Chagas\u2019 disease. N. Engl. J. Med. 370, 1899\u20131908 (2014)","journal-title":"N. Engl. J. Med."},{"key":"BFnature19339_CR21","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","volume":"373","author":"CA Morillo","year":"2015","unstructured":"Morillo, C. A. et al. Randomized trial of benznidazole for chronic Chagas\u2019 cardiomyopathy. N. Engl. J. Med. 373, 1295\u20131306 (2015)","journal-title":"N. Engl. J. Med."},{"key":"BFnature19339_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1586\/14787210.7.2.157","volume":"7","author":"R Viotti","year":"2009","unstructured":"Viotti, R. et al. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities. Expert Rev. Anti Infect. Ther. 7, 157\u2013163 (2009)","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"BFnature19339_CR23","doi-asserted-by":"publisher","first-page":"6385","DOI":"10.1128\/AAC.00689-15","volume":"59","author":"S Khare","year":"2015","unstructured":"Khare, S. et al. Antitrypanosomal treatment with benznidazole is superior to posaconazole regimens in mouse models of Chagas disease. Antimicrob. Agents Chemother. 59, 6385\u20136394 (2015)","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnature19339_CR24","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nm1744","volume":"14","author":"JM Bustamante","year":"2008","unstructured":"Bustamante, J. M., Bixby, L. M. & Tarleton, R. L. Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease. Nature Med. 14, 542\u2013550 (2008)","journal-title":"Nature Med."},{"key":"BFnature19339_CR25","doi-asserted-by":"publisher","first-page":"e2384","DOI":"10.1371\/journal.pntd.0002384","volume":"7","author":"E Myburgh","year":"2013","unstructured":"Myburgh, E. et al. In vivo imaging of trypanosome-brain interactions and development of a rapid screening test for drugs against CNS stage trypanosomiasis. PLoS Negl. Trop. Dis. 7, e2384 (2013)","journal-title":"PLoS Negl. Trop. Dis."},{"key":"BFnature19339_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nature16936","volume":"530","author":"H Li","year":"2016","unstructured":"Li, H. et al. Structure- and function-based design of Plasmodium-selective proteasome inhibitors. Nature 530, 233\u2013236 (2016)","journal-title":"Nature"},{"key":"BFnature19339_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1756-3305-2-29","volume":"2","author":"D Steverding","year":"2009","unstructured":"Steverding, D. & Wang, X. Trypanocidal activity of the proteasome inhibitor and anti-cancer drug bortezomib. Parasites & Vectors 2, 29 (2009)","journal-title":"Parasites & Vectors"},{"key":"BFnature19339_CR28","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.1112680","volume":"309","author":"AC Ivens","year":"2005","unstructured":"Ivens, A. C. et al. The genome of the kinetoplastid parasite, Leishmania major. Science 309, 436\u2013442 (2005)","journal-title":"Science"},{"key":"BFnature19339_CR29","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1093\/jnci\/djq198","volume":"102","author":"X Li","year":"2010","unstructured":"Li, X. et al. Effect of noncompetitive proteasome inhibition on bortezomib resistance. J. Natl. Cancer Inst. 102, 1069\u20131082 (2010)","journal-title":"J. Natl. Cancer Inst."},{"key":"BFnature19339_CR30","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1074\/jbc.M511607200","volume":"281","author":"Y Fernandez","year":"2006","unstructured":"Fernandez, Y. et al. Chemical blockage of the proteasome inhibitory function of bortezomib: impact on tumor cell death. J. Biol. Chem. 281, 1107\u20131118 (2006)","journal-title":"J. Biol. Chem."},{"key":"BFnature19339_CR31","doi-asserted-by":"crossref","unstructured":"Zhang, X., Goncalves, R. & Mosser, D. M. The isolation and characterization of murine macrophages. Curr. Protoc. Immunol. Chapter 14, Unit1 4.1 (2008)","DOI":"10.1002\/0471142735.im1401s111"},{"key":"BFnature19339_CR32","doi-asserted-by":"publisher","first-page":"e1005058","DOI":"10.1371\/journal.ppat.1005058","volume":"11","author":"S Khare","year":"2015","unstructured":"Khare, S. et al. Utilizing chemical genomics to identify cytochrome b as a novel drug target for Chagas disease. PLoS Pathog. 11, e1005058 (2015)","journal-title":"PLoS Pathog."},{"key":"BFnature19339_CR33","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1128\/AAC.40.11.2592","volume":"40","author":"FS Buckner","year":"1996","unstructured":"Buckner, F. S., Verlinde, C. L., La Flamme, A. C. & Van Voorhis, W. C. Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase. Antimicrob. Agents Chemother. 40, 2592\u20132597 (1996)","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnature19339_CR34","doi-asserted-by":"publisher","first-page":"D98","DOI":"10.1093\/nar\/gkr1032","volume":"40","author":"FJ Logan-Klumpler","year":"2012","unstructured":"Logan-Klumpler, F. J. et al. GeneDB\u2013an annotation database for pathogens. Nucleic Acids Res. 40, D98\u2013D108 (2012)","journal-title":"Nucleic Acids Res."},{"key":"BFnature19339_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1472-6750-6-32","volume":"6","author":"MC Taylor","year":"2006","unstructured":"Taylor, M. C. & Kelly, J. M. pTcINDEX: a stable tetracycline-regulated expression vector for Trypanosoma cruzi. BMC Biotechnol. 6, 32 (2006)","journal-title":"BMC Biotechnol."},{"key":"BFnature19339_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0166-6851(93)90240-X","volume":"57","author":"S Hariharan","year":"1993","unstructured":"Hariharan, S., Ajioka, J. & Swindle, J. Stable transformation of Trypanosoma cruzi: inactivation of the PUB12.5 polyubiquitin gene by targeted gene disruption. Mol. Biochem. Parasitol. 57, 15\u201330 (1993)","journal-title":"Mol. Biochem. Parasitol."},{"key":"BFnature19339_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0166-6851(99)00002-X","volume":"99","author":"E Wirtz","year":"1999","unstructured":"Wirtz, E., Leal, S., Ochatt, C. & Cross, G. A. A tightly regulated inducible expression system for conditional gene knock-outs and dominant-negative genetics in Trypanosoma brucei. Mol. Biochem. Parasitol. 99, 89\u2013101 (1999)","journal-title":"Mol. Biochem. Parasitol."},{"key":"BFnature19339_CR38","doi-asserted-by":"crossref","unstructured":"Wilk, S. & Chen, W.-E. Purification of the eukaryotic 20S proteasome. Curr. Protoc. Protein Sci. Chapter 21 (2001)","DOI":"10.1002\/0471140864.ps2106s25"},{"key":"BFnature19339_CR39","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0969-2126(02)00748-7","volume":"10","author":"M Unno","year":"2002","unstructured":"Unno, M. et al. The structure of the mammalian 20S proteasome at 2.75 A resolution. Structure 10, 609\u2013618 (2002)","journal-title":"Structure"},{"key":"BFnature19339_CR40","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1073\/pnas.0511292103","volume":"103","author":"JS Melnick","year":"2006","unstructured":"Melnick, J. S. et al. An efficient rapid system for profiling the cellular activities of molecular libraries. Proc. Natl Acad. Sci. USA 103, 3153\u20133158 (2006)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature19339_CR41","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1002\/jps.21317","volume":"97","author":"NJ Waters","year":"2008","unstructured":"Waters, N. J., Jones, R., Williams, G. & Sohal, B. Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding. J. Pharm. Sci. 97, 4586\u20134595 (2008)","journal-title":"J. Pharm. Sci."},{"key":"BFnature19339_CR42","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1002\/cbdv.200900117","volume":"6","author":"J Wang","year":"2009","unstructured":"Wang, J. & Skolnik, S. Recent advances in physicochemical and ADMET profiling in drug discovery. Chem. Biodivers. 6, 1887\u20131899 (2009)","journal-title":"Chem. Biodivers."},{"key":"BFnature19339_CR43","first-page":"1332","volume":"29","author":"JC Kalvass","year":"2001","unstructured":"Kalvass, J. C., Tess, D. A., Giragossian, C., Linhares, M. C. & Maurer, T. S. Influence of microsomal concentration on apparent intrinsic clearance: implications for scaling in vitro data. Drug Metab. Dispos. 29, 1332\u20131336 (2001)","journal-title":"Drug Metab. Dispos."},{"key":"BFnature19339_CR44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.drudis.2012.09.004","volume":"18","author":"C Li","year":"2013","unstructured":"Li, C. et al. A modern in vivo pharmacokinetic paradigm: combining snapshot, rapid and full PK approaches to optimize and expedite early drug discovery. Drug Discov. Today 18, 71\u201378 (2013)","journal-title":"Drug Discov. Today"},{"key":"BFnature19339_CR45","doi-asserted-by":"crossref","unstructured":"Sacks, D. L. & Melby, P. C. Animal models for the analysis of immune responses to leishmaniasis. Curr. Protoc. Immunol. Chapter 19, Unit 19.12 (2001)","DOI":"10.1002\/0471142735.im1902s28"},{"key":"BFnature19339_CR46","doi-asserted-by":"publisher","first-page":"e2571","DOI":"10.1371\/journal.pntd.0002571","volume":"7","author":"AP McLatchie","year":"2013","unstructured":"McLatchie, A. P. et al. Highly sensitive in vivo imaging of Trypanosoma brucei expressing \u201cred-shifted\u201d luciferase. PLoS Negl. Trop. Dis. 7, e2571 (2013)","journal-title":"PLoS Negl. Trop. Dis."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature19339.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature19339","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature19339.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:54:51Z","timestamp":1684418091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature19339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,8]]},"references-count":46,"journal-issue":{"issue":"7619","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["BFnature19339"],"URL":"https:\/\/doi.org\/10.1038\/nature19339","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,8]]},"assertion":[{"value":"23 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Patents related to this work have been filed (WO 2015\/095477 A1, WO 2014\/151784 A1, WO 2014\/151729). Several authors own shares of Novartis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}